Log In
TZOO
$8.63
(1.47%)
FLWS
$9.31
(1.75%)
ACCO
$4.87
(0.41%)
AUXXF
$0.11
(-3.71%)
ARLP
$21.4
(-0.47%)
ALVOF
$3.5
(0%)
AUIAF
$0.14
(0%)
BSET
$13.5
(0.22%)
BXRX
$0
(0%)
BBGI
$0.74
(6.17%)
BSGM
$1.34
(3.08%)
BLBX
$2.66
(0%)
BOWL
$11.7
(1.39%)
COCP
$1.58
(4.7%)
CDRO
$6.98
(3.56%)
LODE
$0.31
(-2.82%)
CMTL
$1.84
(-1.34%)
CXW
$15.03
(0.4%)
LCE:CA
$0.69
(-1.43%)
CMLS
$2.73
(-1.09%)
DEFN:CA
$0.21
(0%)
DTGI
$0.03
(0%)
DRCT
$6.05
(-1.14%)
DLHC
$10.73
(0.56%)
SSP
$3.71
(0.56%)
EGLE
$0
(0%)
ELMGF
$0.19
(0.16%)
UUUU
$5.36
(0%)
GAME
$1.58
(0%)
EVC
$2.09
(-0.48%)
ESK:CA
$0.36
(-1.35%)
GMBL
$0.65
(0%)
EDRY
$20.67
(1.17%)
ESEA
$34.15
(0.53%)
GNK
$21.39
(0.78%)
GEVO
$0.61
(2.65%)
GRIN
$13.62
(0%)
GTN
$5.74
(-0.61%)
HHS
$7.03
(0.78%)
INDO
$4.25
(2.66%)
IPOOF
$1.8
(-0.55%)
KNDI
$2.66
(-1.12%)
MSGM
$2.39
(-5.16%)
PANL
$6.97
(0.72%)
PXS
$4.51
(0.89%)
QMCI
$0.22
(0%)
SALM
$0.36
(14.25%)
SHIP
$9.6
(1.54%)
TSQ
$12.09
(-0.33%)
TZOO
$8.63
(1.47%)
FLWS
$9.31
(1.75%)

channelchek-in

‌
4/26/2024

Incyte Shells Out $750M for Escient’s Immunology Assets

In a move that further solidifies its position in the inflammatory disease space, Incyte Corporation has agreed to acquire Escient Pharmaceuticals for $750 million. The deal, announced on Tuesday, will add two promising immunology and inflammation candidates to Incyte’s pipeline, complementing its existing dermatology portfolio.

0
3 min read
  • ‌
    Billionaire Leon Cooperman Sounds the Alarm on Looming Financial Crisis

    Billionaire Leon Cooperman Sounds the Alarm on Looming Financial Crisis

    In a characteristically blunt assessment, billionaire investor Leon Cooperman pa...

    3 min read

  • Noble Capital Markets Emerging Growth Virtual Healthcare Conference Presentation Replays

    9 min read

  • Receive FREE Research, News, and Video Updates in your inbox.

  • The New York Stock Exchange’s Bold Proposal for 24/7 Trading: Risks and Opportunities

    4 min read
View all

News

4/26/2024

Incyte Shells Out $750M for Escient’s Immunology Assets

3 min read
‌
Incyte Shells Out $750M for Escient’s Immunology Assets
4/26/2024

Release – ACCO Brands Corporation Declares Quarterly Dividend

2 min read
‌
Release – ACCO Brands Corporation Declares Quarterly Dividend
4/26/2024

Release – Ocugen To Present On Modifier Gene Therapy Platform At Association For Research In Vision And Ophthalmology 2024 Annual Meeting

6 min read
‌
Release – Ocugen To Present On Modifier Gene Therapy Platform At Association For Research In Vision And Ophthalmology 2024 Annual Meeting
4/25/2024

Release – Entravision Schedules First Quarter 2024 Earnings Release and Conference Call

3 min read
‌
Release – Entravision Schedules First Quarter 2024 Earnings Release and Conference Call
View all

Research Reports

Travelzoo (TZOO) – An Improved Balance Sheet; Stable OutlookT(MustGrow Biologics Corp. (MGROF) – Releases Fiscal Year 2023 ResultsMBC(Comstock Inc. (LODE) – Comstock Fuels Gains Commercial MomentumCI(Direct Digital Holdings (DRCT) – Marcum Gives A Bad ImpressionDDH(
View all

Video Content

  • ‌
    DarioHealth Corp.

    DarioHealth Corp.

    Conference Presentation
    4/18/2024
  • ‌
    Cadrenal Therapeutics Inc.

    Cadrenal Therapeutics Inc.

    Conference Presentation
    4/18/2024
  • ‌
    Kiora Pharmaceuticals Inc.

    Kiora Pharmaceuticals Inc.

    Conference Presentation
    4/18/2024
  • ‌
    Anavex Life Sciences Corp.

    Anavex Life Sciences Corp.

    Conference Presentation
    4/18/2024
    • View all

    Movers

    Symbol
    Change
    ZVSA
    681.99%
    BDRX
    82.12%
    PEGY
    50.58%
    FCUV
    50.02%
    CCBI:CA
    49.44%
    View all
    Log In
    © 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.
    Log In